These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 19369356)
1. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions. Kang H; Lieberman PM J Virol; 2009 Jun; 83(12):6199-210. PubMed ID: 19369356 [TBL] [Abstract][Full Text] [Related]
2. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. Stedman W; Kang H; Lin S; Kissil JL; Bartolomei MS; Lieberman PM EMBO J; 2008 Feb; 27(4):654-66. PubMed ID: 18219272 [TBL] [Abstract][Full Text] [Related]
4. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription. Li D; Mosbruger T; Verma D; Swaminathan S J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380 [TBL] [Abstract][Full Text] [Related]
5. CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription. Li DJ; Verma D; Mosbruger T; Swaminathan S PLoS Pathog; 2014 Jan; 10(1):e1003880. PubMed ID: 24415941 [TBL] [Abstract][Full Text] [Related]
6. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. Kang H; Wiedmer A; Yuan Y; Robertson E; Lieberman PM PLoS Pathog; 2011 Aug; 7(8):e1002140. PubMed ID: 21876668 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion. Kang H; Lieberman PM J Virol; 2011 Nov; 85(21):11159-69. PubMed ID: 21880767 [TBL] [Abstract][Full Text] [Related]
8. CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming. Kang H; Cho H; Sung GH; Lieberman PM J Virol; 2013 Feb; 87(3):1789-99. PubMed ID: 23192870 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection. Toth Z; Smindak RJ; Papp B Virology; 2017 Dec; 512():25-33. PubMed ID: 28898712 [TBL] [Abstract][Full Text] [Related]
10. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency. Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481 [TBL] [Abstract][Full Text] [Related]
11. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance. Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870 [TBL] [Abstract][Full Text] [Related]
12. A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. Deng Z; Wang Z; Stong N; Plasschaert R; Moczan A; Chen HS; Hu S; Wikramasinghe P; Davuluri RV; Bartolomei MS; Riethman H; Lieberman PM EMBO J; 2012 Nov; 31(21):4165-78. PubMed ID: 23010778 [TBL] [Abstract][Full Text] [Related]
13. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Li Q; Zhou F; Ye F; Gao SJ Virology; 2008 Sep; 379(2):234-44. PubMed ID: 18684478 [TBL] [Abstract][Full Text] [Related]
14. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403 [TBL] [Abstract][Full Text] [Related]
15. Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus. Schifano JM; Corcoran K; Kelkar H; Dittmer DP J Virol; 2017 Feb; 91(4):. PubMed ID: 27928018 [TBL] [Abstract][Full Text] [Related]
16. Role of CCCTC binding factor (CTCF) and cohesin in the generation of single-cell diversity of protocadherin-α gene expression. Monahan K; Rudnick ND; Kehayova PD; Pauli F; Newberry KM; Myers RM; Maniatis T Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9125-30. PubMed ID: 22550178 [TBL] [Abstract][Full Text] [Related]
17. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248 [TBL] [Abstract][Full Text] [Related]
18. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency. Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201 [TBL] [Abstract][Full Text] [Related]
19. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication. Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712 [TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. Wang SE; Wu FY; Yu Y; Hayward GS J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]